timing of metformi administration and exercise
Not Applicable
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202203690920424
- Lead Sponsor
- Faculty of medicine of sousse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
?Increased waist circumference (=102 cm in men; =88 cm in women)
?Elevated triglycerides (=150 mg/dl), or on medication for treating the condition
?Reduced HDL-cholesterol (<40mg/dl in men, <50 mg/dl in women), or on medication for treating the condition
?High blood pressure (=130 mmHg systolic or =85mmHg diastolic), or on medication for treating the condition
?Elevated fasting glucose (=100 mg/dl), or on medication for treating the condition
Exclusion Criteria
Any condition that counter-indicate exercise
Patients under glucose lowering agents
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Postprandial triglycerides
- Secondary Outcome Measures
Name Time Method Total cholesterol;LDL-cholesterol;HDL-Cholesterol;Glucose;Insulin;Metformin side effects;Perceived appetite sensations